{"nct_id":"NCT05061134","title":"A Study of Ceralasertib Monotherapy and Ceralasertib Plus Durvalumab in Patients With Melanoma and Resistance to PD-(L)1 Inhibition","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-07","start_date":"2022-08-11","start_date_type":"ACTUAL","primary_completion_date":"2024-04-12","primary_completion_date_type":"ACTUAL","completion_date":"2026-11-02","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}